Together, we demonstrate that targeting of the JAK/STAT pathway can inhibit cytokine production, fibroblast-to-myofibroblast transdifferentiation, and fibroproliferation of myofibroblasts, advocating it as a translational target in Dupuytren’s disease. This evidence concerns the gene SOAT1 and Dupuytren Contracture.